CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review

Clinical Trial2017 Aug 22;318(8):713-720.

JOURNAL:JAMA. Article Link

Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

Felker GM, Anstrom KJ1, Adams KF et al. Keywords: Natriuretic Peptide–Guided Therapy; RCT; usual care; Hospitalization; Cardiovascular Mortality ; Heart Failure and Reduced Ejection Fraction

FULL TEXT PDF